TF and hepatocellular carcinoma: The aim of this study was to develop a TF-related prognostic risk model to predict the prognosis, uncover the effect of TF-related signature on immune cell infiltration, and guide the personalized treatment of HCC patients, including chemotherapy and immunotherapy.